GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Weight-loss pill alternatives to weight-loss injection Ozempic could be released as soon as next year if approved by the FDA. Companies such as Novo Nordisk and Eli Lilly have plans to launch ...

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade ...

After comedian Aishwarya Mohanraj revealed using Mounjaro for weight loss, interest surged around the injectable drug ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

WASHINGTON — A pill version of the popular weight-loss drug Wegovy is now available in the United States, offering patients a daily oral option instead of a weekly injection. Danish drugmaker Novo ...

Credit: Novo Nordisk. Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients. The Wegovy tablet is now available ...